LBRX

LB PHARMACEUTICALS INC

LBRX·50180M108·US·Common Stock·Healthcare - Biotechnology-Activist

LBRX (LB PHARMACEUTICALS INC) is held by 68 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($88.7M), RA CAPITAL MANAGEMENT, L.P. ($71.7M), JPMORGAN CHASE & CO ($48.9M). Net institutional sentiment: Bullish.

68
Holders
(4 Elite)
$466.7M
Total Value
84% (64)
Consensus
54 buying - 10 selling
13F: Insider & Congress: Updated regularly
LBRX

Smart Money Verdict

View all
Loading verdict
Held by 68 funds
4 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Sep 16, 2025 · Activists Aug 14, 2026 · Congress none

ActivistTCTCG Crossover GP II, LLC5.0%Aug 14, 2026
ActivistBlackRock, Inc.BlackRock, Inc.6.3%Jul 29, 2026
ActivistJPMORGAN CHASE & COJPMORGAN CHASE & CO5.2%Jul 16, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2.7M(+10.7%)$88.7M0.0%+134.63%
33
Unchanged
2.2M$71.7M0.6%+192.56%
0
Increased
1.5M(+4.9%)$48.9M0.0%+200.25%
31
Increased
971,165(+8.6%)$31.5M0.0%+95.93%
31
Decreased
921,471(-0.2%)$29.9M0.0%+210.89%
0
Unchanged
863,947$28M0.1%+181.07%
0
Increased
612,793(+18.3%)$19.9M0.0%+106.24%
33
Increased
602,028(+19.4%)$19.5M0.0%+98.25%
34
Increased
576,456(+58.5%)$18.7M0.0%+114.03%
40
Increased
540,902(+0.5%)$17.6M0.0%+201.92%
28
Increased
259,219(+89.3%)$8.4M0.0%+72.39%
43
Increased
227,485(+110.0%)$7.4M0.0%+84.92%
44
Decreased
215,969(-48.2%)$7M0.0%+212.11%
0
Unchanged
200,000$6.5M0.0%+216.04%
0
Increased
195,486(+5.0%)$6.3M0.0%+117.64%
29
Decreased
188,907(-15.1%)$6.1M0.0%+215.52%
0
Increased
186,037(+20.5%)$6M0.0%+104.97%
32
Increased
162,801(+3.4%)$5.3M0.0%+99.09%
28
Increased
152,162(+35.3%)$4.9M0.0%+84.28%
35
New
91,656$3M0.0%+48.41%
36

Showing 1-20 of 69

1 / 4
LBRXLBRXLB PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used